Literature DB >> 3743167

Diphenylhydantoin-induced lymphocytic interstitial pneumonia.

D W Chamberlain, R H Hyland, D J Ross.   

Abstract

A patient developed diffuse lymphocytic interstitial pneumonia after receiving diphenylhydantoin therapy for 14 months. Withdrawal of medication resulted in reversal of the disease process. This case illustrates the value of combined transbronchial biopsy and bronchoalveolar lavage sampling in establishing a diagnosis, and the utility of serial bronchoalveolar lavage in monitoring disease evolution.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3743167     DOI： 10.1378/chest.90.3.458

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


  4 in total

Review 1.  Non-neoplastic pulmonary lymphoid lesions.

Authors:  W D Travis; J R Galvin
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

Review 2.  Demystifying idiopathic interstitial pneumonia: time for more etiology-focused nomenclature in interstitial lung disease.

Authors:  Nevins W Todd; Sergei P Atamas; Stella E Hines; Irina G Luzina; Nirav G Shah; Edward J Britt; Andrew J Ghio; Jeffrey R Galvin
Journal:  Expert Rev Respir Med       Date:  2022-01-31       Impact factor: 3.772

3.  Diphenylhydantoin (phenytoin)-induced chronic pulmonary disease.

Authors:  Ramakant Dixit; Kalpana Dixit; Paras Nuwal; Arunima Banerjee; Sidharth Sharma; Lokendra Dave
Journal:  Lung India       Date:  2009-10

4.  Phenytoin-induced acute hypersensitivity pneumonitis.

Authors:  Pallavi Periwal; Sharad Joshi; Rajesh Gothi; Deepak Talwar
Journal:  Lung India       Date:  2015 Nov-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.